Theravance Inc (NASDAQ:THRX)

16.46
Delayed Data
As of Mar 27
 -0.13 / -0.78%
Today’s Change
10.58
Today|||52-Week Range
31.80
+16.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.9B

Company Description

Theravance, Inc. is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. It engages in the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas, including respiratory disease, bacterial infections and central nervous system/pain. The company was founded by P. Roy Vagelos, Mathai Mammen and George M. Whitesides in November 1996 and is headquartered in South San Francisco, CA.

Contact Information

Theravance, Inc.
901 Gateway Boulevard
South San Francisco California 94080
P:(650) 238-9640
Investor Relations:
(650) 808-4100

Employees

Shareholders

Other institutional49.68%
Mutual fund holders40.31%
Individual stakeholders37.86%

Top Executives

Michael W. AguiarPresident, Chief Executive Officer & Director
Frank C. PasqualoneSenior Vice President-Operations
Eric d'EsparbesChief Financial Officer & Senior Vice President
Edmund J. MoranVice President-Research & Development
Junning LeeVice President-Technical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account